Aeris Environmental Ltd. (Aeris) has been notified by the UK Poison Control Centre that its patented hospital-grade hard surface disinfectant, Aeris Active, with residual and validated activity against viruses, has been approved for sale in the United Kingdom (UK). The UK is a major international trading power, with the fifth-largest economy in the world according to the World Bank Group, and the second-largest economy in Europe, with a population of more than 65 million people. Aeris Active contains a `dual active' biocide system, providing broad spectrum viricidal, bactericidal and fungicidal efficacy, together with proprietary `residual protection' affording, in addition to the initial kill, long-term (200 touch or seven day) protection of at-risk surfaces.